The internal dosimetry user group position statement on molecular radiotherapy

Author:

Gear Jonathan12,McGowan Daniel13,Rojas Bruno12,Craig Allison J12,Smith April-Louise14,Scott Catherine J14,Scuffam James15,Aldridge Matthew16,Tipping Jill17

Affiliation:

1. The Internal Dosimetry User Group, England, United Kingdom

2. The Joint Department of Physics, The Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, United Kingdom

3. Radiation Physics and Protection, Oxford University Hospitals NHS Foundation Trust, England, United Kingdom

4. Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, United Kingdom

5. Nuclear Medicine Physics, The Royal Surrey NHS Foundation Trust, England, United Kingdom

6. Maidstone and Royal Tunbridge Wells NHS Trust, England, United Kingdom

7. Nuclear Medicine, The Christie NHS Foundation Trust, England, United Kingdom

Abstract

The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy ( www.IDUG.org.uk ). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK.

Publisher

British Institute of Radiology

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3